HUM
48
2
TROW
51
-2
PSA
58
5
AVGO
35
-2
DRI
56
2
T
48
3
FDX
54
14
EMR
77
-2
BA
45
-3
UA
57
4
XRX
34
-3
QRVO
4
-2
GS
75
-4
DOV
73
4
NOC
40
-10
MS
80
-3
XOM
51
3
STX
52
-4
JCI
61
-2
AMG
43
3
HUM
48
2
TROW
51
-2
PSA
58
5
AVGO
35
-2
DRI
56
2
T
48
3
FDX
54
14
EMR
77
-2
BA
45
-3
UA
57
4
XRX
34
-3
QRVO
4
-2
GS
75
-4
DOV
73
4
NOC
40
-10
MS
80
-3
XOM
51
3
STX
52
-4
JCI
61
-2
AMG
43
3
Financhill
Back

Bruker Vs. Neurogene Industry Stock Comparison

Sell
28

BRKR
Bruker

Last Price:
54.51
Seasonality Move:
5.54%
Sell
5

NGNE
Neurogene

Last Price:
38.98
Seasonality Move:
50.43%
Sell
28
Bruker (BRKR) is a Sell

Is Bruker a Buy, Sell or Hold?

  • The current Bruker [BRKR] share price is $55.95. The Score for BRKR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BRKR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BRKR Stock Price Chart

What is Bruker's stock price today?

  • The Bruker share price today is $55.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRKR is experiencing slight buying pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

BRKR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.8 Sell
Relative Strength Index (14 RSI): 36.78 Sell
Chaikin Money Flow: 83226 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.36 - 62.54) Sell
Bollinger Bands (100): (60.38 - 66.72) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

BRKR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.31 Sell
20-day SMA: 58.97 Sell
50-day SMA: 63.15 Sell
200-day SMA: 71.62 Sell
8-day EMA: 57.59 Sell
20-day EMA: 59.29 Sell
50-day EMA: 61.86 Sell
200-day EMA: 67.3 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

Bruker Earnings Growth & BRKR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.37 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Bruker Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):